Frequency of Eye Diseases in Subjects Aged 40 and Over. Open Journal of Ophthalmology, 15, 11-17. doi: ...
New danger? Popular weight loss drugs and diabetes medications may trigger permanent eye damage! New study raises serious ...
The case for GLP-1 drugs like Ozempic possibly causing blindness is building. A new paper out this week describes several ...
A new review reports that nine people taking semaglutide and tirzepatide — the active ingredient in GLP-1 medications — ...
Google and Perceptra, a Google technology licensing partner, are joining forces to provide AI-powered diabetic-retinopathy (DR) screening to around 1 million people in underserved communities across ...
Researchers have conducted one of the largest eye studies in the world to reveal new insights into retinal thickness, highlighting its potential in the early detection of diseases like type 2 diabetes ...
This article discusses how genetics factor into diabetes development. It also covers the importance of screening and takes a closer look at how genetic testing is being used to diagnose specific types ...
Moran Eye Center at the University of Utah have published an investigatory review of nine patients who experienced vision complications while taking popular semaglutide and tirzepatide drugs ...
SFI may make diabetic retinopathy screening more accessible and affordable. Fundus photography may only take a few minutes, but the complete eye test takes longer. To perform fundoscopy ...
New research published in Cureus has examined the reasons for non-attendance among a small sample of patients eligible for diabetic eye screening at an East Midlands GP practice. The study involved a ...
A case report demonstrates independent effect of GLP-1 receptor agonist.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results